Protalix BioTherapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Protalix BioTherapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 37% to $65,494,000. The net income raised on $8,312,000 and profit margin reached 13%. Total operating expenses were $32,052,000.
Profit Margin
| 2014 | 15.16M | -29.94M | -197.51% |
|---|---|---|---|
| 2015 | 4.36M | 58.03M | 1329.9% |
| 2016 | 9.19M | -29.36M | -319.22% |
| 2017 | 19.24M | -85.27M | -443.18% |
| 2018 | 34.24M | -26.45M | -77.27% |
| 2019 | 54.69M | -26.24M | -47.98% |
| 2020 | 62.89M | -14.89M | -23.68% |
| 2021 | 38.35M | -33.98M | -88.62% |
| 2022 | 47.63M | -14.92M | -31.33% |
| 2023 | 65.49M | 8.31M | 12.69% |
PLX Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 65.49M | 47.63M | 38.35M | 62.89M | 54.69M | 34.24M | 19.24M | 9.19M | 4.36M | 15.16M |
Cost of revenue | 22.98M | 19.59M | 16.34M | 10.87M | 10.89M | 9.30M | 15.23M | 8.39M | 730K | 9.05M |
Gross profit | 42.51M | 28.04M | 22.00M | 52.02M | 43.79M | 24.93M | 4.01M | 801K | 3.63M | 6.10M |
Operating exp. | ||||||||||
Research and development | 17.09M | 29.34M | 29.73M | 38.16M | 44.61M | 33.33M | 28.83M | 24.60M | 20.02M | 21.65M |
Selling and marketing | 0 | 25.29M | 16.74M | 16.23M | 15.86M | 8.97M | 0 | 0 | 0 | 0 |
Total operating expenses | 32.05M | 41.06M | 42.46M | 49.31M | 54.51M | 44.24M | 40.36M | 33.96M | 27.30M | 31.31M |
Operating income | 10.46M | -13.01M | -20.46M | 1.84M | -10.71M | -19.30M | -36.35M | -33.16M | -23.67M | -25.20M |
Other income (expenses), net | -1.89M | -1.38M | -7.12M | -9.23M | -7.55M | -7.14M | 1.83M | 14.06M | -3.61M | -4.73M |
Income before tax | 8.56M | -14.39M | -27.58M | -6.52M | -18.27M | -26.45M | -85.27M | -29.17M | -27.28M | -29.94M |
Income tax expense | 254K | 530K | 6.40M | 8.36M | 7.96M | 536K | 7.80M | 10.85M | -87.56M | -2.94M |
Net income | 8.31M | -14.92M | -33.98M | -14.89M | -26.24M | -26.45M | -85.27M | -29.36M | 58.03M | -29.94M |
Earnings per share | ||||||||||
Basic EPS | 0.12 | -0.31 | -0.77 | -0.51 | -1.77 | -1.8 | -6.51 | -0.29 | 0.61 | -0.32 |
Diluted EPS | 0.1 | -0.31 | -0.77 | -0.51 | -1.77 | -1.8 | -6.51 | -0.29 | 0.61 | -0.32 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |